Kuang-ti Chen
Taitung, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Cholinesterase Inhibitor Reveals Synergistic Potential for Neural Stem Cell-Based Therapy in the 5xFAD Mouse Model of Alzheimer's Disease.
Journal: Biologics : targets & therapy
Published: August 03, 2024
Danshensu Interventions Mediate Rapid Antidepressant Effects by Activating the Mammalian Target of Rapamycin Signaling and Brain-Derived Neurotrophic Factor Release.
Journal: Psychiatry investigation
Published: July 23, 2024
HDAC1 is Involved in Neuroinflammation and Blood-Brain Barrier Damage in Stroke Pathogenesis.
Journal: Journal of inflammation research
Published: May 02, 2023
Activity Dependent Mammalian Target of Rapamycin Pathway and Brain Derived Neurotrophic Factor Release Is Required for the Rapid Antidepressant Effects of Puerarin.
Journal: The American journal of Chinese medicine
Published: October 05, 2018
Acute Amino Acid d-Serine Administration, Similar to Ketamine, Produces Antidepressant-like Effects through Identical Mechanisms.
Journal: Journal of agricultural and food chemistry
Published: November 23, 2017
Antidepressant-like effects of long-term sarcosine treatment in rats with or without chronic unpredictable stress.
Journal: Behavioural brain research
Published: January 29, 2016
AMPA Receptor-mTOR Activation is Required for the Antidepressant-Like Effects of Sarcosine during the Forced Swim Test in Rats: Insertion of AMPA Receptor may Play a Role.
Journal: Frontiers in behavioral neuroscience
Published: March 12, 2015
Inhibition of glycine transporter-I as a novel mechanism for the treatment of depression.
Journal: Biological psychiatry
Published: November 29, 2011
Showing 1-9 of 9
Last Updated: 09/26/2026